Default antiplatelet choice by access route for PPCI
| All (%) | Femoral (%) | Radial (% (p value))* | Radial+ (% (p value))* | |
|---|---|---|---|---|
| Clopidogrel | 28.3 | 50.0 | 25.5 (<0.001) | 20.8 (0.007)† |
| Prasugrel | 36.7 | 25.0 | 38.2 (<0.05) | 32 (0.06)† |
| Ticagrelor | 34.5 | 25.0 | 35.7 (=0.05) | 45.2 (0.018)† |
| Prasugrel or ticagrelor | 71.2 | 50.0 | 73.9 (0.023) | 77.2 (0.001)† |
*Denotes p value when compared to femoral antiplatelet use.
†Denotes p value of <0.0001 for trend across groups.
PPCI, primary percutaneous coronary intervention.